NCT00534547 is a NA clinical trial of Duodenal Exclusion in Diabetes, sponsored by Medtronic - MITG.

Who is sponsoring NCT00534547?

NCT00534547 is sponsored by Medtronic - MITG.

What drugs are being tested in NCT00534547?

Interventions in NCT00534547: Duodenal Exclusion.

Is NCT00534547 still recruiting?

NCT00534547 is currently withdrawn. Last updated 27 July 2015.

Last reviewed 2015-07-27 · How we verify

NCT00534547

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Duodenal Exclusion for the Treatment of Type 2 Diabetes

Withdrawn NA Last updated 27 July 2015

What this trial tests

NA trial testing Duodenal Exclusion in Diabetes. Withdrawn.

Quick facts

Lead sponsor	Medtronic - MITG
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment

Drugs / interventions tested

Duodenal Exclusion

Conditions studied

Diabetes — all drugs for Diabetes →

Sponsor

Medtronic - MITG — full company profile →

Who can join

Adults 20 to 50, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the role of an experimental surgery that may offer better short and long-term control of T2DM in select patients who have not achieved adequate blood sugar control with regular means.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07417865 — ECHO Diabetes FQHC · recruiting

Other Medtronic - MITG trials

Trials by the same sponsor.

NCT07351071 — Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Res · NA · recruiting
NCT07166341 — Accuracy Verification of the INVOS PM7100 · active not recruiting
NCT07201961 — Nellcor™ Abbreviated Sensor Additional Data Collection · completed
NCT06710795 — AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair · NA · active not recruiting
NCT06638073 — Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department o · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00534547 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medtronic - MITG
Last refreshed: 27 July 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00534547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing